From PR Newswire
By
January 24, 2022


Psilera Closes Oversubscribed $8.8M Seed Funding Round to Accelerate Neuroplastogen PSIL-006 Into the Clinic
Psilera Inc., a leading biopharmaceutical company pioneering next-generation neuroplastogens and psychedelic therapies, announced the successful closing of an oversubscribed $8.8 million Series Seed extension funding round led by a syndicate of institutional and strategic investors. The company intends to use the funds to advance its lead clinical asset, PSIL-006, toward first-in-human trials in 2027.
May 27, 2026

Daloopa Raises $47 Million Series C to Power the Data Layer Behind AI-Driven Finance
NEW YORK, May 28, 2026 — Daloopa today announced a $47 million Series C led by Brighton Park Capital, with participation from Squarepoint Capital, Touring Capital, and Nexus Venture Partners, to expand its AI data infrastructure for finance.
May 27, 2026

Basata Raises 21M Series A to Rebuild the 1T Operational Layer of American Healthcare
Basata announced a 21M Series A funding round to rebuild the operational layer of American healthcare with AI agents that automate administrative workflows.
May 7, 2026

Psilera Closes Oversubscribed $8.8M Seed Funding Round to Accelerate Neuroplastogen PSIL-006 Into the Clinic
Psilera Inc., a leading biopharmaceutical company pioneering next-generation neuroplastogens and psychedelic therapies, announced the successful closing of an oversubscribed $8.8 million Series Seed extension funding round led by a syndicate of institutional and strategic investors. The company intends to use the funds to advance its lead clinical asset, PSIL-006, toward first-in-human trials in 2027.
May 27, 2026

Daloopa Raises $47 Million Series C to Power the Data Layer Behind AI-Driven Finance
NEW YORK, May 28, 2026 — Daloopa today announced a $47 million Series C led by Brighton Park Capital, with participation from Squarepoint Capital, Touring Capital, and Nexus Venture Partners, to expand its AI data infrastructure for finance.
May 27, 2026

Basata Raises 21M Series A to Rebuild the 1T Operational Layer of American Healthcare
Basata announced a 21M Series A funding round to rebuild the operational layer of American healthcare with AI agents that automate administrative workflows.
May 7, 2026